ライフサイエンスコーパス: peritoneal fluid

1 ted arachidonic acid (AA) derivatives in the peritoneal fluid.

2 as cerebrospinal fluid, synovial fluid, and peritoneal fluid.

3 s, neutrophil influx, and a pH of 7.9 within peritoneal fluid.

4 asate, but have limited ability to reach the peritoneal fluid.

5 model based on mastocytes isolated from rat peritoneal fluid.

6 A or B) tumors and in cytologically negative peritoneal fluid.

7 ignificantly (P < 0.05) increased tPA in the peritoneal fluid.

8 me-dependent increase in IL-10 in plasma and peritoneal fluid.

9 in biologically active TNF in the plasma and peritoneal fluid.

10 IFNgamma (p = .001) levels were found in the peritoneal fluid.

11 e appearance of TNF or IL-6 in the plasma or peritoneal fluid.

12 thickening (51.2% vs 13.3%, P = .0167), free peritoneal fluid (82.8% vs 33.3%, P = .002), extent of P

13 rget microscopic spheroids persisting in the peritoneal fluid after debulking surgery.

14 e number of viable bacteria in the blood and peritoneal fluid and accelerated killing of bacteria by

15 ive the stresses of anchorage-free growth in peritoneal fluid and ascites, and to colonize remote sit

16 amount of parasite in the brain, spleen, and peritoneal fluid and reducing brain cysts by >85%.

17 Dose-dependent CEA elevation in peritoneal fluid and serum was observed.

18 Among several cytokines surveyed in peritoneal fluid and serum, IL-6 is highly and different

19 orm to enrich ATCs from highly heterogeneous peritoneal fluid and then perform molecular analyses on

20 Peritoneal fluid and tissue were collected at day 1 to m

21 fallopian tube), Peritoneal (viable cells in peritoneal fluid), and Metastatic (cells implanted on ot

22 increased levels of IL-10 in both serum and peritoneal fluid, and increased expression of the IL-10

23 rs, intestinal wet/dry ratios, urine output, peritoneal fluid, and intraluminal fluid were measured.

24 throughout the peritoneum, initially via the peritoneal fluid, and later via ascites that accumulates

25 icited chemokine production in the serum and peritoneal fluid as well as the recruitment of neutrophi

26 antly reduced in splenic homogenates but not peritoneal fluid at 24 hrs.

27 From these patients, we collected cells from peritoneal fluid, blood, lymph, and biopsies.

28 om numerous body sites, including the blood, peritoneal fluid, bone, synovial fluid, a perianal absce

29 The chemokine KC was reduced in the peritoneal fluid but not the plasma and endogenous IL-10

30 VEGF-A was measured in peritoneal fluid by ELISA (n = 16).

31 PDGF AA and BB were quantified in peritoneal fluid by ELISA.

32 Carried by the peritoneal fluid, cancer cell spheroids overcome anoikis

33 elevated of levels of TNF-alpha and CXCL1 in peritoneal fluid compared with wild-type mice.

34 Peritoneal fluid concentrations of prostaglandin E2 (PGE

35 cal adhesion bands were graded on day 7, and peritoneal fluid concentrations of tissue plasminogen ac

36 to lysis of intraperitoneal PMN, because the peritoneal fluids contained free myeloperoxidase and ind

37 The total burden of TP53 mutations in peritoneal fluid distinguished cancers from controls wit

38 Hypermethylation was detected in 28 of 30 peritoneal fluid DNA from stage IC-IV patients, includin

39 There was a significantly lower peritoneal fluid drainage from the ABThera at 48 hours a

40 not seem to be mediated by an improvement in peritoneal fluid drainage, fascial closure rates, or mar

41 these findings using targeted proteomics of peritoneal fluid from endometriosis patients and find gr

42 Postoperative peritoneal fluid from infected patients enhanced both ce

43 els in peritoneal tissue and tPA activity in peritoneal fluid from lovastatin-treated animals were in

44 tations (median mutant fraction 1/13,139) in peritoneal fluid from nearly all patients with and witho

45 wild-type mice and were markedly reduced in peritoneal fluid from septic myeloperoxidase-deficient m

46 els of 3-bromotyrosine also were elevated in peritoneal fluid from septic wild-type mice and were mar

47 We obtained peritoneal fluid from six women with early stage endomet

48 analogue enhancement to study the effect of peritoneal fluid from women with early stage endometrios

49 VEGF-A was increased in peritoneal fluid from women with endometriosis and level

50 significantly lower in the incubations with peritoneal fluid from women with endometriosis than cont

51 etect extremely rare cancer cells present in peritoneal fluid from women with high-grade serous ovari

52 hin peritoneal fluids from these mice, while peritoneal fluids from CLP mice that received preimmune

53 Peritoneal fluids from L-NAME-treated mice contained sig

54 ngly, Gram staining revealed bacteria within peritoneal fluids from these mice, while peritoneal flui

55 Proteomic analysis of the peritoneal fluid identified infection-related proteins,

56 Lower plasma and peritoneal fluid IL-6 concentrations in the IL-6 -174 C-

57 uggest that the presence of bacterial DNA in peritoneal fluid in patients with cirrhosis and ascites

58 undant in both endometriotic lesions and the peritoneal fluid in women with endometriosis.

59 Although plasma and peritoneal fluid levels of IL-33 have been associated wi

60 At 20 hours after CLP, plasma and peritoneal fluid levels of TNF-alpha and IL-6 were deter

61 x that was isolated from the pericardial and peritoneal fluid of a 13-year-old female liver transplan

62 type strain NRRL Y-27500, CBS 2985, from the peritoneal fluid of a dead guinea pig), and K. slooffiae

63 tly fewer total aerobes and anaerobes in the peritoneal fluid of animals challenged with cecal conten

64 ovo secretion of YB-1 into the urine and the peritoneal fluid of LPS-treated mice.

65 INH bound to bacteria cultured from blood or peritoneal fluid of mice with CLP-induced sepsis, but ha

66 RET substrates, we applied the method to the peritoneal fluid of subjects with and without the invasi

67 A, an angiogenic factor, is increased in the peritoneal fluid of women with endometriosis.

68 recurvatus was isolated from the pleural and peritoneal fluids of a 64-year-old man with a history of

69 ly phagocytosed by macrophages prepared from peritoneal fluids of thioglycolate-treated mice.

70 frequency between fallopian tubes exposed to peritoneal fluids of women with and without endometriosi

71 the tumor dose without affecting the dose to peritoneal fluid or bone marrow.

72 no considerable increase was found in either peritoneal fluid or serum after CLP.

73 lation was observed in nonneoplastic tissue, peritoneal fluid, or serum from 40 control women (100% s

74 rebound (P < 0.001), and CT scan findings of peritoneal fluid (P = 0.01), fecalith (P = 0.01), dilati

75 Peritoneal fluid (PF) was obtained by intraoperative lav

76 acteremia and bacterial growth in samples of peritoneal fluid (PF), liver, spleen, kidneys, heart, an

77 Large peritoneal fluid pockets are moderately predictive of ma

78 plasma, serum, milk, urine, amniotic fluid, peritoneal fluid, saliva, follicular fluid, and fluid fr

79 Here, we report the analysis of peritoneal fluid samples from 258 patients with malignan

80 lture techniques for diagnosis of SBP in 106 peritoneal fluid samples from patients with suspected SB

81 TP53 mutation was detected in 94% (16/17) of peritoneal fluid samples from women with HGSOC (frequenc

82 x sequencing to analyze TP53 mutations in 17 peritoneal fluid samples from women with HGSOC and 20 fr

83 d using baseline and postoperative serum and peritoneal fluid samples to determine cell proliferation

84 Culture of the peritoneal fluid showed gram-negative organisms.

85 utrophil infiltration and greater burdens in peritoneal fluid than SC5314 did and abscesses that pers

86 idneys, testis and epididymis with echogenic peritoneal fluid tracking into both scrotal sacs.

87 the PDGFR in ovarian tumors, cell lines and peritoneal fluid using RT-PCR, immunohistochemistry (IHC

88 Fibrinolytic activity in peritoneal fluid was assayed by zymography, and expressi

89 Bacterial load in peritoneal fluid was reduced in CpG ODN-treated versus n

90 hed tumor, preoperative serum or plasma, and peritoneal fluid (washes or ascites) DNA obtained from 5

91 On study days 1, 2, 3, 7, and 28, blood and peritoneal fluid were collected.

92 Blood, stool, and liver biopsies and peritoneal fluid were cultured (circa 4000 total specime